For the first time, a preventative medicine is available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV).  Lori Handy, MD, MSCE, attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, details the science behind the monoclonal antibody, nirsevimab (Beyfortus) and its importance, safety and efficacy, side effects, administration and proven benefits, such as a decrease in morbidity, as shown by clinical trials; and more.

For the first time, a preventative medicine is available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). Lori Handy, MD, MSCE, attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, details the science behind the monoclonal antibody, nirsevimab (Beyfortus) and its importance, safety and efficacy, side effects, administration and proven benefits, such as a decrease in morbidity, as shown by clinical trials; and more.

Primary Care Perspectives: Nirsevimab (Beyfortus) - Episode 154

Listen in as Katie Lockwood, MD, a primary care pediatrician at Children’s Hospital of Philadelphia, discusses hot topics in primary care with CHOP subject-matter-experts as they weigh in on issues affecting the daily practice of pediatricians.

This podcast is for general informational and educational purposes only and is not to be considered as medical advice for any particular patient. Clinicians must rely on their own informed clinical judgment in making recommendations to their patients. ©2017 by Children’s Hospital of Philadelphia, all rights reserved.

Medicine

Health & Fitness

Education

Listen in as Katie Lockwood, MD, a primary care pediatrician at Children’s Hospital of Philadelphia, discusses hot topics in primary care with CHOP subject-matter-experts as they weigh in on issues affecting the daily practice of pediatricians. This podcast is for general informational and educational purposes only and is not to be considered as medical advice for any particular patient. Clinicians must rely on their own informed clinical judgment in making recommendations to their patients. ©2017 by Children’s Hospital of Philadelphia, all rights reserved.

Share Primary Care Perspectives: Nirsevimab (Beyfortus) - Episode 154

Sign up to save your podcasts

Primary Care Perspectives: Nirsevimab (Beyfortus) - Episode 154

Primary Care Perspectives: Nirsevimab (Beyfortus) - Episode 154

More shows like Primary Care Perspectives

AFP: American Family Physician Podcast

JAMA Clinical Reviews

Mayo Clinic Talks

Frankly Speaking About Family Medicine

The Curbsiders Internal Medicine Podcast

Charting Pediatrics

Core IM | Internal Medicine Podcast

Annals On Call Podcast

Public Health On Call

The PedsDocTalk Podcast: Child Health, Development & Parenting—From a Pediatrician Mom

Pediatrics On Call

The Cribsiders

Good Inside with Dr. Becky

Financial Feminist

Why Should I Trust You?